Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Qigong exercise for muscle strength and quality of life during chemotherapy for colorectal cancer

Tests Qigong exercise in people having chemotherapy for colorectal cancer.

Plain-language title generated from the registry record
Registry title: Qigong Exercise for Muscles Strength and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy

Key facts

Where
Giza, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 35 and 55 years old?

Source: NCT07709429, who can take part

Where in Egypt

  • Faculty of Physical Therapy, Cairo UniversityGiza, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cairo University
Trial code
NCT07709429
Record updated
16 July 2026
Original description
The purpose of this study is to evaluate therapeutic effect of Qigong for muscle strength and quality of life in colorectal cancer patients undergoing chemotherapy.Read full original descriptionShow less

Qigong Exercise for Muscles Strength and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy

The purpose of this study is to evaluate therapeutic effect of Qigong for muscle strength and quality of life in colorectal cancer patients undergoing chemotherapy.

Inclusion: Age ranges between 35 and 55 years; Male \& female patients will participate in the study; All patients with colorectal cancer undergoing chemotherapy; All patients enrolled to the study will have their informed consent; The patients will be instructed to report any side effects during the management.

Exclusion: Presence Patients with psychological disturbance or mental illness; Cardiopulmonary disease; Nerve, muscle, or joint disease, or other malignant tumors affecting movement; Autoimmune disease; Hypotensive patients.

ClinicalTrials.gov NCT07709429